ON Holding AG vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? ON Holding AG trades at $34.97 (market cap $11.38B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.41 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.2× ON Holding AG's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while ON Holding AG pays none. Which is the better fit depends on your goals — on Pluang, investors hold ON Holding AG for 22 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| ONON | RPRX | |
|---|---|---|
Market Cap | $11.38B | $25.27B |
Volume | 13,732,872 | 3,671,183 |
Sector | Consumer Cyclical | Health |
52-Week High | $50.63 | $63.96 |
52-Week Low | $26.76 | $35.44 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | $10.54B | $32.50B |
Dividend Yield | — | 1.66% |
Signals from Pluang's Aura AI — not financial advice
ONON trades at $34.79, up 4.73% today, reflecting strong momentum. The stock shows bullish technical signals with support at $33 and resistance at $35. Fundamentally, the company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $0.44 exceeding expectations. Revenue reached $3.01 billion in 2025, with a net income margin of 12.3%. Recent news highlights a $1 billion share buyback plan and ambitious 2029 targets.
The outlook is positive, driven by earnings growth, strategic expansion, and strong analyst support. Key risks include competitive pressures and market volatility. Analysts maintain a consensus buy rating with a $42.26 price target, suggesting potential upside from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →